Fetuin-A is a major plasma glycoprotein released mainly by the liver. Its functions include inhibition of the activity mineralization, etc. Three major functional domains of domains, one inhibiting cysteine protease, and a domain may be considered as a highly pleomorphic protein with metabolic and pathological processes. It could be used as a marker in clinical practice in the future.
Introduction
Fetuin-A is a major plasma glycoprotein, which belongs to the cystatin superfamily of protease inhibitors, and is released mainly by the liver. It performs important functions, including those of inhibition of the insulin receptor activity, and inhibition of bone mineralization been recognized as a multifunctional plasma protein and a key participant in various processes like cellular response, neutrophil and platelet degranulation, lymphocyte stimulation, binding of fatty acids, thyroid hormones and calcium ions, etc.
Fetuin-A was discovered as an important calf serum protein during fetal life by K. O. Pedersen in 1944 [1] . Its homologue in humans was isolated later and was databases of human, mouse, and rat genes [5] . The A and B fetuins were found to be similar in terms of
Structure and function
linked polypeptide chains, both of which are produced by cleavage of a pre-protein, synthesized from a single messenger RNA [7] . The mature form is produced from preprotein after proteolytic processing [8, 9] , and stability and activity [14] . Phosphorylation is essential for fetuin-A interaction with the insulin receptor [15] .
Fetuin-A is a glycoprotein containing major part is that of three N-linked branched heteropolysaccharides of similar composition also has four sites of O-linked glycosylation [17] . The Kratky plot indicates that fetuin-A is mostly a well-ordered globule with a small disordered part [18] . Based on the sequence similarity, it has been demonstrated that fetuin-A glycan mass, the molecular weight determined weight around 55 kDa.
fetuin-B. By structural homology, these proteins belong to the fetuin family and are members of the protease inhibitors, which usually possess a domain of conserved residues necessary for their protease inhibition capacity and four conserved
The cystatin superfamily includes the cystatins themselves, as well as kininogens, histidine-rich
Physiological role
During fetal development, fetuin-A is abundantly fetal calf serum is larger than that of albumin. According to human and animal studies, the highest serum concentration of fetuin-A is
Human fetuin-A function
Fetuin-A inhibits insulin receptor tyrosine kinase, thus impeding autophosphorylation of the insulin receptor, leading to insulin resistance soft tissue, and acts as a potent inhibitor It is a negative acute-phase protein with 
Fetuin-A -calcium chaperone
Fetuin-A is highly associated with the regulation low serum level has been associated with softFetuin-A is involved in the regulation of calcium metabolism, and remodelling of bones, Fetuin-A is a carrier of insoluble calcium calcium and phosphate in the circulation, being an important inhibitor of calcium salt of cardiovascular mortality.
Fetuin-A has a property to stabilize mineral
The selective accumulation of fetuin-A from the cell-dependent process of osteogenesis.
de novo and precipitation of basic calcium circulation may be inhibited by fetuin-A without obstructing bone mineralization. This inhibitory clustering acidic amino acids in domain D1.
that it acts as a calcium chaperone [41] which mediates the transport of minerals from the It may be regarded as an opsonizing serum protein, which stimulates phagocytosis of blood essentially reduces the inhibitory activity of serum proteins on apatite formation.
inhibition was mediated by the transient formation of "calciprotein particles", soluble
These hypothetical calciprotein particles mechanism of the inhibitory effect of fetuin on calcium phosphate crystal formation. Primary fetuin-A and serum albumin, and can be readily effects [45] . The studies on molecular modelling suggested that the inhibition of calciumphosphate deposition is mainly mediated by the cluster of acidic residues on the -sheet of the amino-terminal cystatin-like domain 1 of fetuin-A in volume fraction, while the remaining
In patients with chronic renal failure, liver cancer and liver cirrhosis on long-term dialysis low fetuin-A level might be associated with currently there are no available methods to regulate the levels fetuin-A in circulation. The upregulation of fetuin-A levels may be a have to be taken into account, and its role in insulin resistance in particular. 
Fetuin-A as a hepatokine in nonalcohol induced fatty liver disease
The liver is a central regulator of whole-body glucose and lipid homeostasis. Fetuin-A is a hepatokine that has been proved to have a role in the pathohgenesis of metabolic disease and has liver development [58] . Fat accumulation in the liver in non-alcohol associated with a higher level of fetuin-A in of the liver in the ongoing rise of morbidity in hepatokines, which are engaged in the regulatory effects of clearance and glucose and lipid metabolism. Production of this glycoprotein in It has also been shown that fetuin-A plays an important role in lipid-induced insulin resistance saturated fatty acids via NF-kB activation and increased blood glucose via growth-factor responsive mitogen-activated protein kinase signalling pathways activation Along with the inhibitory effect on insulin saturated fatty acids, preventing the activation
It was shown in a number of studies that the increased production of fetuin-A in patients with hepatic steatosis was closely associated Komsa-Penkova R, et al. Fetuin-a -alpha2-heremans-schmid glycoprotein:... The reduction of body weight in obese hepatic fat content resulted in lowering its serum concentration [57] . It was also shown that even brought a positive response in lowering the serum concentration of this hepatokine despite the fact, that there was no effect on body weight or hepatic triglyceride content as assayed by
© Medical University Pleven

Fetuin-A is an inhibitor of cysteine cathepsins
Fetuin-A is an inhibitor of cysteine cathepsins, which have a key role among the lysosomal family of papain-like cysteine proteases, which are widely distributed among living organisms relations with proteases were demonstrated, trypsin.
is a potential endogenous regulator of meprin suggested to be physiological modulators of meprin activity. The interactions of fetuin-A with proteinases are suggested to be involved in the processes of tumorigenesis and tumor progression. In the -dependent manner, leading to growth of the tumor cells. These studies prove the important role of fetuin-A in serum as a major promoter of growth, that may induce the establishment and growth of a tumor [71] .
Conclusions
the important role of the predominantly liverderived hepatokine fetuin-A in the regulatory effects of clearance and metabolism of glucose and lipids. Apparently, fetuin-A plays a crucial role in the pathogenesis of a number of metabolic disorders and clinically recognized conditions. We present some of the clinical conditions, and regulation of proteolysis. Altogether, data on the mineralization research and correlations various activation biomarkers demonstrate that fetuin-A levels in plasma and tissues could be used as a useful marker in clinical practice in the future.
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fetuin-A, the major globulin of fetal calf serum. 
